Expected US Company Earnings on Tuesday, March 10th, 2026

Blend Labs Inc. Class A (BLND) is expected to report $-0.02 for Q4 2025

United Natural Foods Inc. (UNFI) is expected to report $0.51 for Q2 2026

Consumer Portfolio Services Inc. (CPSS) is expected to report $0.23 for Q4 2025

Westrock Coffee Company (WEST) is expected to report $-0.1 for Q4 2025

Groupon Inc. (GRPN) is expected to report $0.17 for Q4 2025

Tvardi Therapeutics Inc. (TVRD) is expected to report $-0.55 for Q4 2025

Ashtead Group plc ADR (ASHTY) is expected to report $3.22 for Q3 2026

AeroVironment Inc. (AVAV) is expected to report $0.68 for Q3 2026

BioNTech SE (BNTX) is expected to report $-0.22 for Q4 2025

ADC Therapeutics SA (ADCT) is expected to report $-0.32 for Q4 2025

Anixa Biosciences Inc. (ANIX) is expected to report $-0.09 for Q1 2026

The Beachbody Company Inc. (BODI) is expected to report $0.01 for Q4 2025

Infinity Natural Resources (INR) is expected to report $0.65 for Q4 2025

Domo Inc. (DOMO) is expected to report $-0.38 for Q4 2026

Exagen Inc. (XGN) is expected to report $-0.2 for Q4 2025

Custom Truck One Source Inc. (CTOS) is expected to report $0.09 for Q4 2025

Bicycle Therapeutics plc (BCYC) is expected to report $-1 for Q4 2025

Inspired Entertainment Inc. (INSE) is expected to report $0.25 for Q4 2025

Concrete Pumping Holdings Inc. (BBCP) is expected to report $-0.09 for Q1 2026

Auna SA Class A (AUNA) is expected to report $0.13 for Q4 2025

Minerva Neurosciences Inc (NERV) is expected to report $-0.11 for Q4 2025

Ferguson Enterprises Inc. (FERG) is expected to report $3.22 for Q2 2026

Xilio Therapeutics Inc. (XLO) is expected to report $-0.12 for Q4 2025

Commercial Vehicle Group Inc. (CVGI) is expected to report $-0.15 for Q4 2025

Kodiak AI Inc. (KDK) is expected to report $-0.16 for Q4 2025

Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.08 for Q4 2025

Shoulder Innovations Inc. (SI) is expected to report $-0.42 for Q4 2025

Voyager Therapeutics Inc. (VYGR) is expected to report $-0.54 for Q4 2025

ABM Industries Incorporated (ABM) is expected to report $0.87 for Q1 2026

loanDepot Inc. Class A (LDI) is expected to report $-0.06 for Q4 2025

Telomir Pharmaceuticals Inc. (TELO) is expected to report $-0.07 for Q4 2025

Franco-Nevada Corporation (FNV) is expected to report $1.68 for Q4 2025

NIO Inc. American depositary shares each representing one Class A (NIO) is expected to report $-0.05 for Q4 2025

Pangaea Logistics Solutions Ltd. (PANL) is expected to report $0.18 for Q4 2025

Achieve Life Sciences Inc. (ACHV) is expected to report $-0.27 for Q4 2025

Cadre Holdings Inc. (CDRE) is expected to report $0.41 for Q4 2025

Bioceres Crop Solutions Corp. (BIOX) is expected to report $0.07 for Q2 2026

Cyclerion Therapeutics Inc. (CYCN) is expected to report $-0.38 for Q4 2025

Esperion Therapeutics Inc. (ESPR) is expected to report $0.23 for Q4 2025

Priority Technology Holdings Inc. (PRTH) is expected to report $0.29 for Q4 2025

Kohl's Corporation (KSS) is expected to report $0.85 for Q4 2026

Ovid Therapeutics Inc. (OVID) is expected to report $-0.1 for Q4 2025

Legend Biotech Corporation (LEGN) is expected to report $-0.17 for Q4 2025

Modiv Industrial Inc. Class C (MDV) is expected to report $0.37 for Q4 2025

Apyx Medical Corporation (APYX) is expected to report $-0.06 for Q4 2025

JOYY Inc. (JOYY) is expected to report $1.33 for Q4 2025

Synchronoss Technologies Inc. (SNCR) is expected to report $0.12 for Q4 2025

Allbirds Inc. (BIRD) is expected to report $-2.25 for Q4 2025

Vireo Growth Inc Com (VREOF) is expected to report $0.01 for Q4 2025

Werewolf Therapeutics Inc. (HOWL) is expected to report $-0.34 for Q4 2025

Eve Holding Inc. (EVEX) is expected to report $-0.15 for Q4 2025

Skye Bioscience Inc. (SKYE) is expected to report $-0.29 for Q4 2025

Q32 Bio Inc. (QTTB) is expected to report $-0.84 for Q4 2025

Rapport Therapeutics Inc. (RAPP) is expected to report $-0.65 for Q4 2025

Oracle Corporation (ORCL) is expected to report $1.34 for Q3 2026

Instil Bio Inc. (TIL) is expected to report $-2.31 for Q4 2025

Lyell Immunopharma Inc. (LYEL) is expected to report $-2.14 for Q4 2025

Stagwell Inc. (STGW) is expected to report $0.25 for Q4 2025